PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
+33.7%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$4.23B
AUM Growth
+$1.6B
(+61%)
Cap. Flow
+$935M
Cap. Flow
% of AUM
22.08%
Top 10 Holdings %
Top 10 Hldgs %
21.32%
Holding
1,174
New
230
Increased
606
Reduced
167
Closed
168
Top Buys
| 1 |
KE Holdings
BEKE
|
+$78.6M |
| 2 |
Lufax Holding
LU
|
+$56.6M |
| 3 |
Groupon
GRPN
|
+$50.3M |
| 4 |
JD.com
JD
|
+$43.7M |
| 5 |
Lands' End
LE
|
+$36.7M |
Top Sells
| 1 |
JMIA
Jumia Technologies
JMIA
|
+$35.9M |
| 2 |
Peloton Interactive
PTON
|
+$31.3M |
| 3 |
Match Group
MTCH
|
+$23.5M |
| 4 |
Fiverr
FVRR
|
+$16.6M |
| 5 |
Stitch Fix
SFIX
|
+$14.7M |
Sector Composition
| 1 | Consumer Discretionary | 35.59% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 13.86% |
| 4 | Real Estate | 4.37% |
| 5 | Industrials | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Xencor
XNCR
$600M
| $57K | ﹤0.01% |
1,320
+830
| +169% | +$35.8K |
|
|
KLRS
677
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.8M
| $57K | ﹤0.01% |
+65
| New | +$57K |
|
678
Willis Towers Watson
WTW
$32.4B
| $56K | ﹤0.01% |
270
+32
| +13% | +$6.64K |
|
679
Mettler-Toledo International
MTD
$27.1B
| $55K | ﹤0.01% |
49
+15
| +44% | +$16.8K |
|
680
Simon Property Group
SPG
$59.6B
| $55K | ﹤0.01% |
646
+136
| +27% | +$11.6K |
|
681
Equifax
EFX
$31.2B
| $52K | ﹤0.01% |
277
+52
| +23% | +$9.76K |
|
682
Seres Therapeutics
MCRB
$200M
| $51K | ﹤0.01% |
105
+67
| +176% | +$32.5K |
|
683
Sangamo Therapeutics
SGMO
$157M
| $51K | ﹤0.01% |
3,270
+2,066
| +172% | +$32.2K |
|
684
Stoke Therapeutics
STOK
$1.21B
| $51K | ﹤0.01% |
830
+544
| +190% | +$33.4K |
|
685
Grifois
GRFS
$6.88B
| $50K | ﹤0.01% |
2,740
+1,666
| +155% | +$30.4K |
|
686
Teladoc Health
TDOC
$1.38B
| $50K | ﹤0.01% |
254
-278
| -52% | -$54.7K |
|
|
CERN
687
DELISTED
Cerner Corp
CERN
| $50K | ﹤0.01% |
648
+104
| +19% | +$8.03K |
|
688
Arthur J. Gallagher & Co
AJG
$76.7B
| $49K | ﹤0.01% |
402
+96
| +31% | +$11.7K |
|
689
Ameriprise Financial
AMP
$46.4B
| $49K | ﹤0.01% |
254
+50
| +25% | +$9.65K |
|
|
IGMS
690
DELISTED
IGM Biosciences
IGMS
| $49K | ﹤0.01% |
+555
| New | +$49K |
|
691
Liberty Broadband Class C
LBRDK
$8.69B
| $49K | ﹤0.01% |
314
-2,334
| -88% | -$364K |
|
692
Take-Two Interactive
TTWO
$45.9B
| $49K | ﹤0.01% |
238
+34
| +17% | +$7K |
|
693
Best Buy
BBY
$16.3B
| $48K | ﹤0.01% |
490
-588
| -55% | -$57.6K |
|
694
Zentalis Pharmaceuticals
ZNTL
$118M
| $48K | ﹤0.01% |
+930
| New | +$48K |
|
|
NGM
695
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $48K | ﹤0.01% |
1,585
+997
| +170% | +$30.2K |
|
|
COUP
696
DELISTED
Coupa Software Incorporated
COUP
| $48K | ﹤0.01% |
144
-300
| -68% | -$100K |
|
697
Labcorp
LH
$23B
| $47K | ﹤0.01% |
+272
| New | +$47K |
|
698
Boston Beer
SAM
$2.45B
| $47K | ﹤0.01% |
+48
| New | +$47K |
|
699
Corpay
CPAY
$22B
| $47K | ﹤0.01% |
174
+38
| +28% | +$10.3K |
|
700
Nkarta
NKTX
$151M
| $46K | ﹤0.01% |
+750
| New | +$46K |
|